India’s healthcare landscape has undergone a remarkable transformation over the decades, with the advent of modern corporate hospitals leading to a surge in quality patient care. However, this standard of care is largely confined to tertiary care, leaving room for improvement in primary and secondary care. The convergence of healthcare and digital technology, such as telemedicine, wearable devices, and remote monitoring, presents an opportunity to revolutionize primary care delivery. Digital health tools enable healthcare providers to gain a comprehensive view of patient health, but standardized processes, clear SOPs, and advanced technology infrastructure are often lacking. By leveraging digital healthcare, a measurable framework can be established to enhance patient experience and clinical outcomes. India has the potential to become a global hub for dental and cosmetic treatments, but standardized quality parameters are needed to empower patients in making informed choices. Digital health companies can play a pivotal role in implementing these standards, particularly in dental care, setting a precedent for excellence that can extend to other medical specialties.
Results for: Digital Health
Midi Health, a telehealth platform designed to serve women in midlife, has raised $60 million in Series B funding. The platform connects women with providers trained in perimenopause and menopause symptoms and treatments. Midi Health’s unique approach focuses on building long-term relationships between patients and providers, offering a personalized and holistic care experience.
Pelago, a renowned digital clinic partnered with U.S. businesses and health plans for substance use management, recently announced the integration of cannabis into its specialized substance use disorder (SUD) treatments. This groundbreaking program, set to be fully implemented by Q3 2024, expands Pelago’s current digital substance use treatment solutions, which focus on tobacco, alcohol, and opioids. The program launch stems from Pelago’s recent $58 million funding round and marks the first large-scale digital cannabis use treatment program in the United States. Pelago’s cannabis program aims to address the rising prevalence of cannabis use disorders (CUDs) while simultaneously tackling the decline in treatment rates. By implementing evidence-based and clinically sound approaches, Pelago empowers individuals who use cannabis to understand its impact on their health and facilitates informed decision-making. The program leverages cognitive behavioral therapy and motivational enhancement therapy/interviewing at launch, with plans to incorporate contingency management in 2024.